Get the Stockscreener App
1.06
3.92%
0.04
Sutro Biopharma Inc stock is traded at $1.06, with a volume of 1.09M.
It is up +3.92% in the last 24 hours and up +30.38% over the past month.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
See More
Previous Close:
$1.02
Open:
$1.02
24h Volume:
1.09M
Relative Volume:
1.43
Market Cap:
$89.86M
Revenue:
$153.73M
Net Income/Loss:
$-106.79M
P/E Ratio:
-0.5955
EPS:
-1.78
Net Cash Flow:
$-115.93M
1W Performance:
+23.67%
1M Performance:
+30.38%
6M Performance:
-22.06%
1Y Performance:
-75.29%
1-Day Range:
$1.01
$1.18
1-Week Range:
$0.86
$1.18
52-Week Range:
$0.5231
$4.80
Sutro Biopharma Inc Stock (STRO) Company Profile
Name
Sutro Biopharma Inc
Sector
Industry
Phone
650-392-8412
Address
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Compare STRO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
1.06 | 86.47M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-17-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-14-25 | Downgrade | BofA Securities | Buy → Underperform |
| Mar-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Mar-14-25 | Downgrade | Wedbush | Outperform → Neutral |
| May-08-24 | Initiated | BofA Securities | Buy |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-06-23 | Initiated | Oppenheimer | Outperform |
| Mar-21-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-18-22 | Resumed | Wells Fargo | Overweight |
| Jun-18-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-20 | Initiated | Stifel | Buy |
| Sep-02-20 | Initiated | Jefferies | Buy |
| Jul-16-20 | Initiated | Wells Fargo | Overweight |
| Jan-13-20 | Initiated | SunTrust | Buy |
| Oct-07-19 | Initiated | BTIG Research | Buy |
| Jul-18-19 | Initiated | Deutsche Bank | Buy |
| Apr-29-19 | Initiated | H.C. Wainwright | Buy |
| Oct-22-18 | Initiated | JMP Securities | Mkt Outperform |
| Oct-22-18 | Initiated | Piper Jaffray | Overweight |
| Oct-22-18 | Initiated | Wedbush | Outperform |
View All
Sutro Biopharma Inc Stock (STRO) Latest News
Is Sutro Biopharma Inc. a top pick in the sectorTrade Entry Report & Smart Swing Trading Techniques - 강소기업뉴스
What indicators show strength in Sutro Biopharma Inc.2025 Volume Leaders & Advanced Swing Trade Entry Alerts - Newser
sutro biopharma inc. stock chart pattern explained2025 Volatility Report & Verified Entry Point Signals - Newser
Using fundamentals and technicals on Sutro Biopharma Inc.July 2025 Spike Watch & Daily Oversold Bounce Ideas - Newser
Using data tools to time your Sutro Biopharma Inc. exitEarnings Risk Report & Stepwise Trade Execution Plans - Newser
Price action breakdown for Sutro Biopharma Inc.Quarterly Market Review & Long-Term Growth Portfolio Plans - Newser
Can you recover from losses in Sutro Biopharma Inc.Weekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Published on: 2025-09-06 20:20:33 - Newser
Reversal indicators forming on Sutro Biopharma Inc. stock2025 Sector Review & Real-Time Market Sentiment Reports - Newser
How institutional ownership impacts Sutro Biopharma Inc. stockJuly 2025 EndofMonth & Reliable Trade Execution Plans - Newser
Risk vs reward if holding onto Sutro Biopharma Inc.Weekly Trade Summary & Verified Momentum Watchlists - Newser
What the charts say about Sutro Biopharma Inc. todayWeekly Trend Recap & Verified Stock Trade Ideas - Newser
There's No Escaping Sutro Biopharma, Inc.'s (NASDAQ:STRO) Muted Revenues Despite A 25% Share Price Rise - 富途牛牛
Ranking Sutro Biopharma Inc. among high performing stocks via toolsEarnings Miss & Daily Technical Stock Forecast Reports - Newser
Is Sutro Biopharma Inc. still worth holding after the dipCEO Change & Long-Term Capital Growth Strategies - Newser
Sutro Biopharma, Inc. $STRO Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Published on: 2025-09-04 22:52:21 - Newser
What makes Sutro Biopharma Inc. stock price move sharplyInsider Buying & Safe Capital Allocation Plans - Newser
Using data filters to optimize entry into Sutro Biopharma Inc.July 2025 Setups & Low Risk Profit Maximizing Plans - Newser
What’s the outlook for Sutro Biopharma Inc.’s sectorJuly 2025 Analyst Calls & High Accuracy Swing Trade Signals - خودرو بانک
Is Sutro Biopharma Inc. reversing from oversold territory2025 Price Momentum & High Accuracy Swing Trade Signals - Newser
What is the Moat Score of Sutro Biopharma Inc.July 2025 Catalysts & Consistent Profit Trade Alerts - خودرو بانک
Measuring Sutro Biopharma Inc.’s beta against major indices2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - Newser
Sutro Biopharma Inc. stock chart pattern explainedFed Meeting & Real-Time Buy Signal Alerts - Newser
Market reaction to Sutro Biopharma Inc.’s recent news2025 EndofYear Setup & Proven Capital Preservation Methods - Newser
Using data models to predict Sutro Biopharma Inc. stock movementMarket Movement Recap & Daily Oversold Stock Bounce Ideas - Newser
What is Sutro Biopharma Inc. s P E ratio telling usJuly 2025 Summary & Verified Short-Term Plans - خودرو بانک
How to recover losses in Sutro Biopharma Inc. stockJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - Newser
What machine learning models say about Sutro Biopharma Inc.July 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Real time breakdown of Sutro Biopharma Inc. stock performanceJuly 2025 Final Week & Pattern Based Trade Signal System - Newser
Sutro Biopharma Inc. stock daily chart insightsEarnings Recap Report & Fast Moving Stock Watchlists - Newser
Is it time to cut losses on Sutro Biopharma Inc.2025 Market Overview & Comprehensive Market Scan Insights - Newser
What’s the recovery path for long term holders of Sutro Biopharma Inc.Portfolio Update Summary & Community Consensus Trade Alerts - Newser
Is Sutro Biopharma Inc. stock poised for growthJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - Newser
Investment Report: What is the target price for Sutro Biopharma Inc. stock2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Using AI based signals to follow Sutro Biopharma Inc.Portfolio Value Report & Fast Moving Stock Trade Plans - Newser
What’s the MACD signal for Sutro Biopharma Inc.July 2025 Recap & Consistent Profit Trade Alerts - خودرو بانک
Block Trades: Is now the right time to enter Sutro Biopharma Inc.Jobs Report & Risk Managed Investment Signals - خودرو بانک
Sutro Biopharma Inc Stock (STRO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sutro Biopharma Inc Stock (STRO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chung Jane | Chief Executive Officer |
Aug 09 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
117,058 |
| ALBINI EDWARD C | CFO AND SECRETARY |
May 15 '25 |
Option Exercise |
0.00 |
44,719 |
0 |
176,800 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
37,849 |
0 |
133,282 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
54,580 |
| Borgman Anne Elizabeth | CHIEF MEDICAL OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
69,063 |
0 |
122,161 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
Apr 11 '25 |
Option Exercise |
0.00 |
21,250 |
0 |
59,683 |
| NEWELL WILLIAM J | CEO |
Mar 05 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
299,239 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
99,027 |
| ALBINI EDWARD C | CFO AND SECRETARY |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
135,675 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 04 '25 |
Option Exercise |
0.00 |
9,125 |
0 |
94,025 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):